BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 865 filers reported holding BAXTER INTL INC in Q3 2016. The put-call ratio across all filers is 0.50 and the average weighting 0.3%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $226,000 | -99.6% | 2,700 | -99.6% | 0.01% | -99.6% |
| Q3 2019 | $57,284,000 | +7.6% | 654,894 | +0.7% | 2.13% | +4.8% |
| Q2 2019 | $53,249,000 | -6.9% | 650,176 | -7.6% | 2.03% | -3.0% |
| Q1 2019 | $57,209,000 | +5.9% | 703,591 | -14.3% | 2.09% | -23.2% |
| Q4 2018 | $54,027,000 | -46.8% | 820,829 | -37.7% | 2.73% | -21.7% |
| Q3 2018 | $101,552,000 | +6.8% | 1,317,316 | +2.3% | 3.48% | +1.7% |
| Q2 2018 | $95,123,000 | +10.6% | 1,288,236 | -2.5% | 3.42% | +8.9% |
| Q1 2018 | $85,978,000 | -10.5% | 1,321,931 | -0.8% | 3.14% | -5.1% |
| Q4 2017 | $96,019,000 | +15.7% | 1,333,046 | +0.8% | 3.31% | +3.3% |
| Q3 2017 | $82,994,000 | -1.7% | 1,322,611 | -5.1% | 3.21% | -4.9% |
| Q2 2017 | $84,397,000 | +14.7% | 1,394,075 | -1.7% | 3.37% | +20.0% |
| Q1 2017 | $73,559,000 | +14.2% | 1,418,415 | -2.3% | 2.81% | +7.4% |
| Q4 2016 | $64,395,000 | -6.7% | 1,452,305 | +0.2% | 2.62% | -11.5% |
| Q3 2016 | $68,988,000 | +4.1% | 1,449,325 | -1.1% | 2.96% | -0.3% |
| Q2 2016 | $66,268,000 | +9.3% | 1,465,460 | -0.7% | 2.97% | +7.6% |
| Q1 2016 | $60,602,000 | +48.8% | 1,475,210 | +38.2% | 2.76% | +45.3% |
| Q4 2015 | $40,732,000 | – | 1,067,670 | – | 1.90% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GENERATION INVESTMENT MANAGEMENT LLP | 21,171,371 | $1,817,350,000 | 7.47% |
| Soditic Asset Management LLP | 147,620 | $12,672,000 | 6.53% |
| NUANCE INVESTMENTS, LLC | 4,084,218 | $350,589,000 | 6.17% |
| PRAGMA GESTAO DE PATRIMONIO LTD | 145,000 | $12,447 | 5.96% |
| Veritas Asset Management LLP | 12,222,261 | $1,049,159,000 | 5.89% |
| Pavadi Capital LLC | 72,782 | $6,248,000 | 4.74% |
| Sonen Capital LLC | 48,907 | $4,198,000 | 4.06% |
| Glenview Capital Management | 2,182,422 | $187,339,000 | 3.99% |
| Dash Acquisitions Inc. | 103,963 | $8,924,000 | 3.87% |
| Avidity Partners Management LP | 1,765,000 | $151,508,000 | 3.21% |